ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,69
0,14%
Dow Jones
43 325,80
0,07%
DAX
19 848,77
-0,34%
Brent Oil
72,90
-0,53%
Bitcoin
95 517,84
-3,81%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. ReShape Lifesciences Inc (RSLS) Cours

ReShape Lifesciences Inc

ReShape Lifesciences Inc (RSLS)

NASDAQ
4,75
0,30
(6,74%)
À la fermeture: 26 Décembre 10:00PM
Retardé de 15 minutes
4,75
0,00
( 0,00% )
Après les heures de négociation: 10:44PM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
4,75
Prix Achat
4,50
Prix Vente
4,95
Volume échangé
11 399
4,40 Fourchette du Jour 4,75
4,09 Plage de 52 semaines 29,00
Cap du marché
3,385M
Clôture Veille
4,45
Ouverture
4,40
Dernière Transaction
20
@
4.52
Dernière heure de transaction
23:15:34
Volume financier
US$ 51 586
VWAP
4,5255
Volume moyen (3 m)
92 713
Actions en circulation
712 680
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,30
Bénéfice par action (BPA)
-15,98
Chiffre d'affairess
8,68M
Bénéfice net
-11,39M

À propos de ReShape Lifesciences Inc

Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, a... Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, and ReShapeCare, a virtual coaching program delivered through an app. Show more

Secteur
Surgical,med Instr,apparatus
Industrie
Surgical,med Instr,apparatus
Site Web
www.reshapelifesciences.com
Siège social
Wilmington, Delaware, USA
Fondé
-
ReShape Lifesciences Inc est coté dans le secteur Surgical,med Instr,apparatus de la NASDAQ avec le ticker RSLS. Le dernier cours de clôture d'ReShape Lifesciences était de US$4,45. Au cours de la dernière année, les actions de ReShape Lifesciences ont été négociées dans une fourchette de prix de US$ 4,09 à US$ 29,00.

ReShape Lifesciences compte actuellement 712 680 actions en circulation. La capitalisation boursière d'ReShape Lifesciences est de US$3,17 million. ReShape Lifesciences a un ratio cours/bénéfice (ratio PE) de -0.30.

RSLS Dernières nouvelles

Plus de nouvelles

Form S-1 - General form for registration of securities under the Securities Act of 1933

20 Décembre 2024
Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations

11 Décembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

11 Décembre 2024
Edgar (US Regulatory)

Form S-4/A - Registration of securities, business combinations: [Amend]

06 Décembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

02 Décembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

14 Novembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

14 Novembre 2024
Edgar (US Regulatory)

ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update

Revenue Increased 16.6% in the Third Quarter of 2024 Over the Second Quarter, Representing the Third Sequential Quarter of Growth, and 6.4% Compared to the Same Period in 2023 Significant...

14 Novembre 2024
GlobeNewswire Inc.

ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update

IRVINE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it...

12 Novembre 2024
GlobeNewswire Inc.

ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX

IRVINE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Health...

12 Novembre 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.255.555555555564.54.754.26185754.39490269CS
4-0.99-17.24738675965.745.944.09292974.91697575CS
12-0.67-12.36162361625.427.24.09927135.61033192CS
26-6.328-57.122224228211.07816.59964.0971213210.82196669CS
52-12.36-72.238457042717.11294.09197552213.69093349CS
156-5737.25-99.9172762104574257714.091515202160.29053879CS
260-748.38-99.369298793753.13275504.0914274803160.3628477CS

RSLS - Frequently Asked Questions (FAQ)

What is the current ReShape Lifesciences share price?
The current share price of ReShape Lifesciences is US$ 4,75
How many ReShape Lifesciences shares are in issue?
ReShape Lifesciences has 712 680 shares in issue
What is the market cap of ReShape Lifesciences?
The market capitalisation of ReShape Lifesciences is USD 3,17M
What is the 1 year trading range for ReShape Lifesciences share price?
ReShape Lifesciences has traded in the range of US$ 4,09 to US$ 29,00 during the past year
What is the PE ratio of ReShape Lifesciences?
The price to earnings ratio of ReShape Lifesciences is -0,3
What is the cash to sales ratio of ReShape Lifesciences?
The cash to sales ratio of ReShape Lifesciences is 0,39
What is the reporting currency for ReShape Lifesciences?
ReShape Lifesciences reports financial results in USD
What is the latest annual turnover for ReShape Lifesciences?
The latest annual turnover of ReShape Lifesciences is USD 8,68M
What is the latest annual profit for ReShape Lifesciences?
The latest annual profit of ReShape Lifesciences is USD -11,39M
What is the registered address of ReShape Lifesciences?
The registered address for ReShape Lifesciences is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the ReShape Lifesciences website address?
The website address for ReShape Lifesciences is www.reshapelifesciences.com
Which industry sector does ReShape Lifesciences operate in?
ReShape Lifesciences operates in the SURGICAL,MED INSTR,APPARATUS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
EVAXEvaxion Biotech AS
US$ 1,57
(85,58%)
6,69M
RVSNRail Vision Ltd
US$ 1,15
(48,66%)
3,14M
LIDRAEye Inc
US$ 1,8495
(44,49%)
1,47M
KITTNauticus Robotics Inc
US$ 2,5207
(41,61%)
4,2M
CRKNCrown Electrokinetics Corporation
US$ 0,1801
(36,75%)
25,53M
VIRXViracta Therapeutics Inc
US$ 0,199
(-16,03%)
299,8k
XELBXcel Brands Inc
US$ 0,45
(-13,28%)
33,27k
LKCOLuokung Technology Corporation
US$ 1,63
(-12,37%)
16,78k
RAYRaytech Holding Ltd
US$ 1,39
(-12,03%)
10,88k
CTCXCarmell Corporation
US$ 0,288
(-10,56%)
143,71k
CRKNCrown Electrokinetics Corporation
US$ 0,1823
(38,42%)
25,53M
OMEXOdyssey Marine Exploration Inc
US$ 0,614
(27,78%)
9,33M
EVAXEvaxion Biotech AS
US$ 1,57
(85,58%)
6,69M
KITTNauticus Robotics Inc
US$ 2,5207
(41,61%)
4,2M
XTIAXTI Aerospace Inc
US$ 0,0401
(0,25%)
3,87M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
RSLS
ReShape Lifesciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés